---
schema_version: "secwatch.filing_event.v1"
accession: "0000012208-26-000034"
form_type: "8-K"
ticker: "BIO"
cik: "0000012208"
company_name: "BIO-RAD LABORATORIES, INC."
filed_at: "2026-04-30T23:59:59+00:00"
generated_at: "2026-05-15T00:34:21.435901+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Bio-Rad Q1 GAAP net loss $527M ($19.55/share); net sales +1.1% to $592.1M

## Summary
- Net sales $592.1M, up 1.1% YoY; GAAP gross margin 52.3% (flat YoY), non-GAAP gross margin 53.1%.
- GAAP net loss $527.1M (diluted EPS -$19.55) vs prior-year net income $64.0M ($2.29).
- Non-GAAP net income $50.9M ($1.89 diluted EPS); non-GAAP operating income $39.3M, down from $63.0M.
- Operating cash flow $108.1M; free cash flow $78.1M; repurchased ~176k shares during Q1.
- Management cited challenging academic markets and Middle East conflict as headwinds.

## SEC filing metadata
- accession: 0000012208-26-000034
- form_type: 8-K
- ticker: BIO
- cik: 0000012208
- company_name: BIO-RAD LABORATORIES, INC.
- filed_at: 2026-04-30T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/12208/000001220826000034/0000012208-26-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/12208/000001220826000034/bio-20260430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000012208-26-000034
- JSON: https://secwatch.observer/filing/0000012208-26-000034.json
- Plain text: https://secwatch.observer/filing/0000012208-26-000034.txt

## Key facts
- Earnings Releases
  BIO-RAD LABORATORIES, INC. reported first quarter ended March 31, 2026 results: revenue $592.1 million, net income $(527.1) million, EPS $(19.55) per diluted share.
  - Period: first quarter ended March 31, 2026
  - Revenue: $592.1 million
  - Net income: $(527.1) million
  - EPS: $(19.55) per diluted share
  - Result: reported results
  source text: Financial Results Highlights GAAP Results Q1 2026 Q1 2025 Net sales (millions) $ 592.1 $ 585.4 Gross margin 52.3 % 52.3 % Income from operations (millions) $ 34.1 $ 23.7 Net income (loss) (millions) $ (527.1) $ 64.0 Income (loss) per diluted share $ (19.55) $ 2.29
  evidence_url: https://www.sec.gov/Archives/edgar/data/12208/000001220826000034/0000012208-26-000034-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.